Trypacidin is a fungal metabolite originally isolated fromA. fumigatus.¹It is active againstB. subtilisandM. bovis(MICs = 12.5 and 1.25 µg/ml, respectively), as well asT. cruziandT. gondii(MICs = 5-10 and 10-20 µg/ml, respectively).^1,2It reduces viability and induces lysis of A549 human lung cancer cells (IC₅₀s = 7.4 µM for both).³Trypacidin increases survival in a mouse model ofT. gondiiinfection when administered in six doses of 12.5 mg/kg each.¹

1.Balan, J., Ebringer, L., Nemec, P., et al.Antiprotozoal antibiotics. II. Isolation and characterization of trypacidin, a new antibiotic, active against Trypanosoma cruzi and Toxoplasma gondiiJ. Antibiot. (Tokyo)16157-160(1963) 2.Song, Z., Liu, Y., Gao, J., et al.Antitubercular metabolites from the marine-derived fungus strain Aspergillus fumigatus MF029Nat. Prod. Res.1-8(2019) 3.Gauthier, T., Wang, X., Dos Santos, J.S., et al.Trypacidin, a spore-borne toxin from Aspergillus fumigatus, is cytotoxic to lung cellsPLoS One7(2)e29906(2012)